Form 8-K - Current report:
SEC Accession No. 0001193125-24-215168
Filing Date
2024-09-06
Accepted
2024-09-06 16:09:31
Documents
17
Period of Report
2024-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875709d8k.htm   iXBRL 8-K 54533
2 EX-4.1 d875709dex41.htm EX-4.1 724654
3 EX-99.1 d875709dex991.htm EX-99.1 13141
4 EX-99.2 d875709dex992.htm EX-99.2 16135
8 GRAPHIC g875709dsp7.jpg GRAPHIC 6246
  Complete submission text file 0001193125-24-215168.txt   1113724

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA jazz-20240903.xsd EX-101.SCH 2859
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20240903_lab.xml EX-101.LAB 18689
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20240903_pre.xml EX-101.PRE 11692
20 EXTRACTED XBRL INSTANCE DOCUMENT d875709d8k_htm.xml XML 3815
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 241284585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)